HR Execs on the Move

C. R. Bard

www.crbard.com

 
C. R. Bard is a leading multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of Vascular, Urology, Oncology, and Surgical Specialties. Bard markets its products and services worldwide to hospitals, individual health care professionals, extended care facilities, and alternate site facilities. Bard pioneered the development of single-patient-use medical products for hospital procedures; today Bard is dedicated to pursuing technological innovations that offer superior clinical benefits while helping to reduce overall health care costs.
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.crbard.com
  • 730 Central Ave
    New Providence, NJ USA 07974
  • Phone: 908.277.8000

Executives

Name Title Contact Details
Matt Winkler
Director, Research and Development Profile
Vaughn Cassingham
Director Research and Development Profile
William Bock
VP Customer Operations Profile
Andrew Sheffield
R&D Director Profile
David Cano
Vice President - Human Resources Profile

Similar Companies

Seventh Sense Biosystems

Seventh Sense Biosystems is a privately held medical technology company focused on developing innovative blood collection devices used in research and clinical testing. Our mission is to eliminate the barriers to successful blood sample collection and testing for health care professionals and consumers with simple, safe, mobile, and nearly painless technologies.

Direct Action Medical Network

Direct Action Medical Network is a Alexandria, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Guided Therapeutics

Guided Therapeutics, Inc is a Norcross, GA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Orion Medical Supply

Orion Medical Supply is a Vancouver, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

TELA Bio

TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient`s own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient`s natural healing response while minimizing long-term exposure to permanent synthetic materials.